Standard therapy stopped working.
First-line chemotherapy fails for many patients with advanced cancer. You then wait for the next scan to confirm what your body already knows — and start over.
OmixMe's personalized medical analysis identifies your unique genetic profile, empowering doctors to replace standard chemotherapy with targeted therapies that improve cancer survival rates and reduce side effects.
4 Hidden Risks of Using Standard Statistics Over Molecular Biology for Cancer Treatment.
First-line chemotherapy fails for many patients with advanced cancer. You then wait for the next scan to confirm what your body already knows — and start over.
Two patients with the same diagnosis can receive the same protocol — and the same protocol can fail for entirely different molecular reasons. Without reading your tumour's DNA, every decision is partly a guess.
Trial-and-error treatment costs months per failed protocol. In advanced cancer, time is the one thing you cannot buy back.
The majority of trials require molecular data your hospital doesn't routinely generate. Without that data, you remain a generic candidate — never a verified molecular match.
We integrate deep DNA sequencing, liquid biopsy blood monitoring, and AI-driven clinical trial matching to provide your oncologist with a molecular GPS for highly targeted cancer care.
We sequence cancer-relevant genes and analyse RNA expression so your doctor can see molecular signals that standard biopsies don't reveal.
Sequencing and analysing an individual's entire DNA to identify genetic mutations, structural changes, and other genomic alterations associated with disease, including cancer.
Your molecular profile is matched against the global evidence base to help predict which therapies are most likely to work on your specific tumour — not on an average patient.
The process is straightforward and physician-led:
In ideal circumstances, the patient's physician will receive the completed molecular analysis within approximately 14–30 days after the tumour sample has been received and confirmed for processing.
No vague "insights." No 4-page summaries. Four concrete deliverables, in your hands within two weeks.
Plain-English summary up front. Full clinical-grade detail in the back — written so your oncologist can act on it on day one.
We provide your oncologist with precise analysis of your tumour, which will help him set up the best possible therapy for a specific tumour in a particular patient.
Sequenced from your tumour. DNA, RNA expression and ctDNA in one panel.
From sample arrival to your full report in 2 weeks – 1 month. Not 6 months. Not 2 months. Days.
Standard chemotherapy
Objective response rate in the same molecularly defined disease.
Matched targeted therapy
Across well-validated targets like EGFR, ALK, and BRAF.
Sources: JCO Precision Oncology (2021) · Therapeutic Advances in Medical Oncology (2022).
Sample collection, sequencing, AI interpretation, written report, expert consultation, and direct dialogue with your oncologist. Whether your tumour sample is 30 mg, 500 mg, or just a 10 mL blood draw — the process is the same.
Once we have consulted with your oncologist to understand your specific clinical needs, we will generate a customized quote based on their input. We will then send you the price no commitment required and no hidden costs. The whole package, nothing separately billed later.
Connect us with your doctorWe handle the logistics, the lab work, the interpretation, and the conversation with your oncologist. You and your family stay focused on what matters — your treatment and recovery.
A standard lab returns variants. We return decisions your care team can act on.
OmixMe helps patients gain:
This approach helps clarify the biological nature of the disease and supports more personalized care decisions.
We'd rather lose a sale than enroll a patient OmixMe can't actually help. Read both columns.
"I've heard about personalized medicine and biomarker testing by OmixMe. I'd like to analyze my tumor sample to see if there's a therapy targeting my specific molecular typos."
"I want the most advanced plan possible. Can we use personalized analytics to assess molecular data and personalize my cancer treatment?"
And if you'd rather we coordinate with your oncologist directly — that's exactly what we do.
If yours isn't here, ask us in the form below. We answer every email in person.
Every week of standard trial-and-error is a week your tumour evolves. In a matter of days you could be holding a treatment plan written for your biology — not the average patient's.
Connect us with your doctorWe coordinate with your treating oncologist directly. No commitment required.
Share a few details below and we'll reach out to your treating oncologist with everything they need to evaluate whether OmixMe is the right next step for your care.
Rapid Reporting
An accelerated workflow so your doctor receives the report quickly.
Confidential & Secure
Your medical data remains private and is never shared without your explicit consent.
Transparent, Fixed Pricing
A comprehensive quote with no commitment and no hidden costs.
Doctor-first
Every finding is reviewed with — and delivered to — your treating physician, who remains your primary medical contact.